What is the role of particle morphology in pharmaceutical powder aerosols?

Expert Opinion on Drug Delivery

Volumn 5, Issue 8, 2008, Pages 909-914

  Chan, Hak Kim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma; Dry powder inhaler; Inhalation therapy; Particle morphology; Respiratory diseases

Indexed keywords

CROMOGLYCATE DISODIUM; LACTOSE PERMEASE; NANOPARTICLE; NEDOCROMIL; SALBUTAMOL SULFATE;

AEROSOL; ASTHMA; ATOMIC FORCE MICROSCOPY; CRYSTAL STRUCTURE; DENSITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; DRY POWDER; MORPHOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; POROSITY; POWDER INHALER; QUANTITATIVE ANALYSIS; REVIEW; SOLID STATE; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG CARRIERS; DRUG STABILITY; EXCIPIENTS; HUMANS; LACTOSE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES;

EID: 52049118554     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.5.8.909     Document Type: Review

References (24)

1. Reuters. Eli Lilly drops inhaled insulin program. MSNBC. Available from: http://wwwmsnbcmsncom/id/23527042/ [Last accessed 7 March 2008]
2. Inhale Therapeutics. Inhale to Develop a Second Inhaleable Antibiotic in Chiron Collaboration. 17 July 2002. Available from: http://www.nektar.com/wt/page/pr_1026938000/?ref=Archived_press_Releases
3. UKMi Central. Inhaled iloprost (Ventavis) gets EU approval for pulmonary hypertension. 23 September 2003. Available from: http://www.ukmicentral.nhs.uk/headline/database/ viewnewssearch.asp?offset=3510&NewsID=2611
4. Pharmaxis. Aridol. Available from: http://www.pharmaxis.com.au/products/ aridol/aridol_home.cfm
5. Chan H-K. Dry powder aerosol delivery systems: current and future research directions. J Aerosol Med 2006;19:21-7
6. Crowder TM, Rosati JA, Schroeter JD, et al. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development. Pharm Res 2002;19(3):239-45
7. Coates MS, Fletcher DF, Chan H-K, Raper JA. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1. Grid structure and mouthpiece length. J Pharm Sci 2004;93:2863-76
8. Finlay WH. The mechanics of inhaled pharmaceutical aerosols: an introduction. London: Academic Press; 2001.
9. Ganderton D, Kassem NM. Dry powder inhalers. Advances in pharmaceutical sciences. London: Academic Press; 1992. p. 165-91
10. Young PM, Cocconi D, Colombo P, et al. Characterization of a surface modified dry powder inhalation carrier prepared by 'particle smoothing'. J Pharm Pharmacol 2002;54:1339-44
11. Zimon AD. Adhesion of dust and powder. Plenum Press, New York; 1969
12. Zeng XM, Martin GP, Marriott C, Pritchard J. The influence of carrier morphology on drug delivery by dry powder inhalers. Int J Pharm 2000;200:93-106
13. Larhrib H, Martin GP, Marriott C, Prime D. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm 2003;257:283-96
14. Ikegami K, Kawashima Y, Takeuchi H, et al. Improved inhalation behavior of steroid KSR-592 in vitro with Jethaler(R) by polymorphic transformation to needle-like crystals (beta-Form). Pharm Res 2002;19(10):1439-45
15. Timbrell V. The inhalation of fibrous dusts. Ann NY Acad Sci 1965;132:255-73
16. Gonda I, Khalik AFAE. On the calculation of aerodynamic diameter of fibers. Aerosol Sci Technol 1985;4:233-8
17. Chan H-K, Gonda I. Respirable form of crystals of cromoglycic acid. J Pharm Sci 1989;78:176-80
18. Chan H-K, Gonda I. Physicochemical characterization of a new respirable form of nedocromil. J Pharm Sci 1995;84:692-6
19. Chew N, Chan H-K. Use of solid corrugated particles to enhance powder aerosol performance. Pharm Res 2001;18:1570-7
20. Chew NY, Tang P, Chan H-K, Raper JA. How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharm Res 2005;22:148-52
21. Heng D, Tang P, Cairney JM, et al. Focused-ion-beam milling: a novel approach to probing the interior of particles used for inhalation aerosols. Pharm Res 2007;24:1608-17
22. Chan H-K. The role of particle morphology in powder inhalers. In: Byron PR, Peart J, Suman JD, editors, Proceedings of the Respiratory Drug Delivery. Davis Healthcare International Publishing: River Grove, IL, Europe; 2007. p. 187-96
23. Cantor AS, Stefely JS, Jinks PA, et al. Modifying interparticulate interactions using surface-modified excipient nanoparticles. In: Byron PR, Peart J, Suman JD, et al., editors, Proceedings of the Respiratory Drug Delivery. Davis Healthcare International Publishing: River Grove, IL; 2008. p. 309-18
24. Kawashima Y, Serigano T, Hino T, et al. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int J Pharm 1998;172:179-88